Tackling polypharmacy in psychiatryClose to 60% of patients in U.S. national ambulatory survey were prescribed two or more psychotropic medications in 2005, a sharp rise from the 42.6% seen in 1996. ADHD in the spotlight: What doctors need to know about this ‘trending’ diagnosis Q&A: Two Canadian ADHD experts talk about why there is a surge of patients seeking assessment, the importance of a formal diagnosis, and what physicians need to know to recognize and treat the disorder Updates in the management of behavioural and psychological symptoms of dementia New guidelines aim to equip healthcare professionals to better treat and support patients and their caregivers. QUIZ: Delving into depression The Canadian Network for Mood and Anxiety Treatments recently updated its clinical guideline for the management of major depressive disorder. Are you up-to-date on the latest developments? Find out here! How is the STAIRS treatment model for MDD different? Study protocol outlines STAIRS interventions for functional and personal recovery. Cannabis used by youth under 18 increases risk for schizophrenia Use linked to changes in grey and white matter in the brain. Executives of U.S. telehealth company accused of fraud that gave easy access to addictive Adderall drug The actions of Done Global are alleged to have contributed to the ongoing shortage of ADHD medication. Not all placebo effects are the same Which psychiatric conditions benefit the most? Obsessive-compulsive disorder common among medical trainees Female students, younger trainees, depression and stress increase the risk. Screen all adolescent patients for eating disorders, new pediatric guidance says Dr. Holly Agostino, lead author of the guidelines, says wait times for eating disorder programs have grown dramatically. First Previous 4 5 6 7 8 Next Last
